![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
Baxter Beats, Raises Outlook – Analyst Blog
Zacks Market Commentaries (October 15th, 2009) Writes:
Baxter International Inc. (BAX) today reported third quarter fiscal 2009 earnings per share of 98 cents, surpassing the Zacks Consensus Estimate of 97 cents and the year-ago earnings of 88 cents. The company also raised its outlook for full fiscal 2009.
Sales
Net sales in the quarter were roughly flat year over year at $3.1 billion. An unfavorable foreign currency translation (FX) adversely affected net sales. Excluding FX, net sales increased approximately 6% year over year. On a geographic basis, domestic sales accounted for approximately 42% of total sales and increased 5% year over year. International sales declined 4% year over year.
In terms of business segments: BioScience revenues increased 2% year over year to approximately $1.4 billion. Growth was due to higher sales of recombinant products (including ADVATE), antibody therapies and biosurgery products. This was partly offset by lower demand for plasma proteins. ...
Tags for this Post:
Analyst, anesthesia products, Baxter International Inc., Becton, biosurgery products, cent;, dialysis, Dickinson and Company;, European Union, H1N1, hemophilia, Infectious Diseases, Investing Lessons, Johnson & Johnson, kidney disease, Medical Products, peritoneal dialysis, recombinant products, Stocks to Watch, Swine Flu;, USD, Zacks Market Commentaries
Analyst, anesthesia products, Baxter International Inc., Becton, biosurgery products, cent;, dialysis, Dickinson and Company;, European Union, H1N1, hemophilia, Infectious Diseases, Investing Lessons, Johnson & Johnson, kidney disease, Medical Products, peritoneal dialysis, recombinant products, Stocks to Watch, Swine Flu;, USD, Zacks Market Commentaries
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.